Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ERAS-007 |
| Trade Name | |
| Synonyms | ASN007|ASN-007|ASN 007|ERAS007|ERAS 007 |
| Drug Descriptions |
ERAS-007 (ASN007) is a small molecule that inhibits ERK1/2, which may result in decreased tumor cell proliferation and reduced tumor growth (PMID: 34337566). |
| DrugClasses | ERK Inhibitor (pan) 21 |
| CAS Registry Number | NA |
| NCIT ID | C150248 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + Encorafenib + ERAS-007 | Cetuximab ERAS-007 Encorafenib | 1 | 1 |
| Copanlisib + ERAS-007 | Copanlisib ERAS-007 | 1 | 0 |
| ERAS-007 | ERAS-007 | 8 | 2 |
| ERAS-007 + ERAS-601 | ERAS-007 ERAS-601 | 0 | 0 |
| ERAS-007 + Gilteritinib | ERAS-007 Gilteritinib | 0 | 1 |
| ERAS-007 + Osimertinib | ERAS-007 Osimertinib | 0 | 1 |
| ERAS-007 + Palbociclib | ERAS-007 Palbociclib | 0 | 1 |
| ERAS-007 + Sotorasib | ERAS-007 Sotorasib | 0 | 1 |